Test Price
2,800 AED✅ Home Collection Available
IKBKG Gene Ectodermal Dysplasia, Hypohidrotic, with Immune Deficiency Genetic Test in UAE – 2,800 AED – DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited Next‑Generation Sequencing (NGS).
- Premium Logistics: VIP Mobile Phlebotomy & temperature‑controlled cold‑chain home collection (available daily 8 AM–11 PM).
- Clinical Guidance: Telephonic post‑test clinical guidance for result interpretation and genetic counseling.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test screens the IKBKG gene for mutations causing X‑linked hypohidrotic ectodermal dysplasia with immune deficiency (EDA‑ID). The assay uses Next‑Generation Sequencing (NGS) to detect single nucleotide variants, small insertions/deletions, and copy number variations with near‑exhaustive coverage of all coding exons. Results empower dermatologists, clinical immunologists, and medical geneticists to confirm diagnosis, guide therapy, and inform family planning.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% sensitivity, full gene coverage | Targeted exons only; misses deep intronic variants |
| Method | Next‑Generation Sequencing (Illumina) | Capillary electrophoresis‑based |
| Speed | 3–4 weeks (comprehensive report) | 4–6 weeks (limited data) |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403), states: “An isolated IKBKG result is not a diagnosis; it must be interpreted alongside clinical features, sweat testing, and immunoglobulin levels. We urge patients to maintain their prescribed therapies unless otherwise directed by their managing physician.”
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. The test does not replace ongoing medical management.
Exclusion Criteria & Emergency Red Flags
- Inability to provide a venous blood specimen or FTA card sample (e.g., severe anemia, inaccessible veins).
- Individuals lacking the legal capacity to consent, unless a legally authorized representative is present.
- Seek immediate medical attention if the patient develops high fever, severe respiratory distress, or signs of disseminated infection – these may indicate a life‑threatening immunodeficiency crisis unrelated to the test.
Patient FAQ & Clinical Guidance
1. What is the clinical purpose of the IKBKG gene NGS test?
This test diagnoses X‑linked hypohidrotic ectodermal dysplasia with immune deficiency by detecting disease‑causing IKBKG variants. The report guides treatment for recurrent infections and ectodermal abnormalities.
2. How is the sample collected and what logistics apply in the UAE?
A certified phlebotomist collects a blood or FTA card sample at your home using ISO cold‑chain transport. Processing takes 3–4 weeks. WhatsApp scheduling is available 8 AM–11 PM daily.
3. When will I receive my results and what support is included?
Results are delivered in 3–4 weeks including a detailed clinical interpretation, genetic counseling session, and direct billing verification via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
This test is performed at DNA Labs UAE under DHA Facility License No. 1143 (Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE). All patient data are handled in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | IKBKG Gene – Ectodermal Dysplasia, Hypohidrotic, with Immune Deficiency (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or FTA card dried blood spot |
| Methodology Used | Next‑Generation Sequencing (Illumina), full coding exon coverage |
| ICD‑10‑CM Code | Q82.4 (Ectodermal dysplasia) – D84.9 (Immunodeficiency, unspecified) |
| LOINC Code | 58000‑6 (Genetic analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians